{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:00:24Z","timestamp":1787061624809,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T00:00:00Z","timestamp":1384387200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s12028-013-9899-x","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T14:57:00Z","timestamp":1384354620000},"page":"140-146","source":"Crossref","is-referenced-by-count":27,"title":["Stroke, IL-1ra, IL1RN, Infection and Outcome"],"prefix":"10.1007","volume":"21","author":[{"given":"Kyra J.","family":"Becker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorender","family":"Dankwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dannielle","family":"Zierath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Tanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Cain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Dressel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,14]]},"reference":[{"key":"9899_CR1","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1172\/JCI115453","volume":"88","author":"WP Arend","year":"1991","unstructured":"Arend WP. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest. 1991;88:1445\u201351.","journal-title":"J Clin Invest"},{"key":"9899_CR2","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/0888-7543(92)90137-H","volume":"13","author":"A Steinkasserer","year":"1992","unstructured":"Steinkasserer A, Spurr NK, Cox S, Jeggo P, Sim RB. The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci. Genomics. 1992;13:654\u20137.","journal-title":"Genomics"},{"key":"9899_CR3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-065X.2008.00624.x","volume":"223","author":"WP Arend","year":"2008","unstructured":"Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev. 2008;223:20\u201338.","journal-title":"Immunol Rev"},{"key":"9899_CR4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.11.009","volume":"18","author":"V Banwell","year":"2009","unstructured":"Banwell V, Sena ES, Macleod MR. Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. J Stroke Cerebrovasc Dis. 2009;18:269\u201376.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"9899_CR5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12028-010-9490-7","volume":"14","author":"P Tanzi","year":"2011","unstructured":"Tanzi P, Cain K, Kalil A, et al. Post-stroke infection: a role for IL-1ra? Neurocrit Care. 2011;14:244\u201352.","journal-title":"Neurocrit Care"},{"key":"9899_CR6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2377-11-110","volume":"11","author":"WF Westendorp","year":"2011","unstructured":"Westendorp WF, Nederkoorn PJ, Vermeij JD, Dijkgraaf MG, van de Beek D. Post-stroke infection: a systematic review and meta-analysis. BMC Neurol. 2011;11:110.","journal-title":"BMC Neurol"},{"key":"9899_CR7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1468-1331.2003.00749.x","volume":"11","author":"S Aslanyan","year":"2004","unstructured":"Aslanyan S, Weir CJ, Diener HC, Kaste M, Lees KR. Pneumonia and urinary tract infection after acute ischemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol. 2004;11:49\u201353.","journal-title":"Eur J Neurol"},{"key":"9899_CR8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2249.1995.tb05549.x","volume":"99","author":"VA Danis","year":"1995","unstructured":"Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol. 1995;99:303\u201310.","journal-title":"Clin Exp Immunol"},{"key":"9899_CR9","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K","volume":"28","author":"M Hurme","year":"1998","unstructured":"Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol. 1998;28:2598\u2013602.","journal-title":"Eur J Immunol"},{"key":"9899_CR10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-3083.1998.00300.x","volume":"47","author":"S Santtila","year":"1998","unstructured":"Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol. 1998;47:195\u20138.","journal-title":"Scand J Immunol"},{"key":"9899_CR11","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/ALN.0b013e318216e9cb","volume":"114","author":"KA Candiotti","year":"2011","unstructured":"Candiotti KA, Yang Z, Morris R, et al. Polymorphism in the interleukin-1 receptor antagonist gene is associated with serum interleukin-1 receptor antagonist concentrations and postoperative opioid consumption. Anesthesiology. 2011;114:1162\u20138.","journal-title":"Anesthesiology"},{"key":"9899_CR12","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0016-5085(99)70338-0","volume":"117","author":"NA Tountas","year":"1999","unstructured":"Tountas NA, Casini-Raggi V, Yang H, et al. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology. 1999;117:806\u201313.","journal-title":"Gastroenterology"},{"key":"9899_CR13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2141.2010.08318.x","volume":"150","author":"AM Rocha","year":"2010","unstructured":"Rocha AM, De Souza C, Rocha GA, et al. IL1RN VNTR and IL2-330 polymorphic genes are independently associated with chronic immune thrombocytopenia. Br J Haematol. 2010;150:679\u201384.","journal-title":"Br J Haematol"},{"key":"9899_CR14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1164\/rccm.200905-0722OC","volume":"180","author":"J Smolonska","year":"2009","unstructured":"Smolonska J, Wijmenga C, Postma DS, Boezen HM. Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20\u00a0years\u2019 research. Am J Respir Crit Care Med. 2009;180:618\u201331.","journal-title":"Am J Respir Crit Care Med"},{"key":"9899_CR15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ibd.20757","volume":"15","author":"DM Queiroz","year":"2009","unstructured":"Queiroz DM, Oliveira AG, Saraiva IE, et al. Immune response and gene polymorphism profiles in Crohn\u2019s disease and ulcerative colitis. Inflamm Bowel Dis. 2009;15:353\u20138.","journal-title":"Inflamm Bowel Dis"},{"key":"9899_CR16","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/1529-0131(200110)44:10<2387::AID-ART403>3.0.CO;2-7","volume":"44","author":"J Vencovsky","year":"2001","unstructured":"Vencovsky J, Jarosova K, Ruzickova S, et al. Higher frequency of allele 2 of the interleukin-1 receptor antagonist gene in patients with juvenile idiopathic arthritis. Arthritis Rheum. 2001;44:2387\u201391.","journal-title":"Arthritis Rheum"},{"key":"9899_CR17","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/j.1440-1746.2010.06428.x","volume":"25","author":"H Xue","year":"2010","unstructured":"Xue H, Lin B, Ni P, Xu H, Huang G. Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis. J Gastroenterol Hepatol. 2010;25:1604\u201317.","journal-title":"J Gastroenterol Hepatol"},{"key":"9899_CR18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/jnnp.2006.093104","volume":"78","author":"G Gromadzka","year":"2007","unstructured":"Gromadzka G, Sarzynska-Dlugosz I, Czlonkowska A. IL1RN intron 2 polymorphism caused by variable number tandem repeats is associated with 1\u00a0year outcome in patients with ischemic stroke. J Neurol Neurosurg Psychiatry. 2007;78:183\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9899_CR19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.gene.6364393","volume":"8","author":"S Rafiq","year":"2007","unstructured":"Rafiq S, Stevens K, Hurst AJ, et al. Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels. Genes Immun. 2007;8:344\u201351.","journal-title":"Genes Immun"},{"key":"9899_CR20","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/ATVBAHA.108.167437","volume":"28","author":"AP Reiner","year":"2008","unstructured":"Reiner AP, Wurfel MM, Lange LA, et al. Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation. Arterioscler Thromb Vasc Biol. 2008;28:1407\u201312.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9899_CR21","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1212\/WNL.0b013e3181aa5329","volume":"72","author":"JR Sims","year":"2009","unstructured":"Sims JR, Gharai LR, Schaefer PW, et al. ABC\/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology. 2009;72:2104\u201310.","journal-title":"Neurology"},{"key":"9899_CR22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.191.2.303","volume":"191","author":"MJ Nicklin","year":"2000","unstructured":"Nicklin MJ, Hughes DE, Barton JL, Ure JM, Duff GW. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med. 2000;191:303\u201312.","journal-title":"J Exp Med"},{"key":"9899_CR23","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s00125-008-1160-3","volume":"51","author":"S Rafiq","year":"2008","unstructured":"Rafiq S, Melzer D, Weedon MN, et al. Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes. Diabetologia. 2008;51:2205\u201313.","journal-title":"Diabetologia"},{"key":"9899_CR24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.06.008","volume":"22","author":"K Becker","year":"2013","unstructured":"Becker K, Tanzi P, Kalil A, Shibata D, Cain K. Early statin use is associated with increased risk of infection after stroke. J Stroke Cerebrovasc Dis. 2013;22:66\u201371.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"9899_CR25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-1331.2007.02015.x","volume":"15","author":"J Montaner","year":"2008","unstructured":"Montaner J, Chacon P, Krupinski J, et al. Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial. Eur J Neurol. 2008;15:82\u201390.","journal-title":"Eur J Neurol"},{"key":"9899_CR26","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/jnnp.2004.054882","volume":"76","author":"HC Emsley","year":"2005","unstructured":"Emsley HC, Smith CJ, Georgiou RF, et al. A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry. 2005;76:1366\u201372.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-013-9899-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12028-013-9899-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-013-9899-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:14:37Z","timestamp":1559427277000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12028-013-9899-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,14]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["9899"],"URL":"https:\/\/doi.org\/10.1007\/s12028-013-9899-x","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,14]]}}}